Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer

DOI Web Site 1 Citations
  • Mahdi Gharaibeh
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA;
  • Ali McBride
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA;
  • J. Lyle Bootman
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA;
  • Hitendra Patel
    University of Arizona Cancer Center, Tucson, AZ, USA
  • Ivo Abraham
    Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA;

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top